FDA Warning Letter — Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Case 598303 — FEI 3014877770

The FDA took a Warning Letter action against Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy on January 14, 2020 (Bristol, TN). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Date
January 14, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Bristol, TN (United States)